anyETF
New ETF
$BONR

Boner ETF

Rising to meet the moment, whatever the market does.

+$16,137.53 (+161.38%)Past 5 years
$10,000 invested in $BONR
Yearly return
average since Oct 1995
Beat the S&P 500
by this much a year
Biggest drop
from its high, 2015–2020
Holdings
bigger names weigh more, max 25%

The backtest starts in Oct 1995, as far back as our price data goes. Companies that went public later join the quarter after their IPO, like Dr. Reddy's Laboratories in 2001.

Criteria

  1. 1The company sells products that treat erectile dysfunction.
  2. 2The company's main business is pharmaceuticals or healthcare products.
  3. 3The company would gain significant revenue if erectile dysfunction became widespread in the USA.
  4. 4The company is publicly traded in the United States.

Composition

LLY+36%PFE+11%TEVA+99%VTRS+80%RDY−12%AMRX+93%HIMS−46%
Size is weight, color is the past year’s return.−30%+30%

Holdings

CompanyWeight